Cell expansion for clinical applications is mainly performed in the presence of fetal
calf serum (FCS). As FCS is known to cause disease transmission and incorporation
of xenogenic proteins during cultivation, alternative supplements for cell culture
media are desired. In recent years, human serum (huS) and human platelet lysate (hPL)
turned out to be as potential or even better when used instead of FCS. We established
production processes for huS and two different types of hPL in the last years. Now
their efficacy in application as cell culture supplement should be determined.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to CytotherapyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Article info
Publication history
43
Identification
Copyright
© 2013 Published by Elsevier Inc.
